Relief From Neuropathic Pain
D’OXYVA® (deoxyhemoglobin vasodilator) is a novel, clinically validated blood flow and nerve stimulant for people suffering from Neuropathy. In multiple clinical trials, D’OXYVA has validated leading independent research results and demonstrated above-average results in improving a host of physiological functions at the same time.
Subjects suffering from high blood sugar have reported neuropathy pain relief minutes after D’OXYVA was administered and long-term blood sugar level improvements in just a few weeks.
In human clinical trials the rapid and gentle transdermal (over-the-skin) delivery of the D’OXYVA device has improved the blood microcirculation or perfusion index (PI) by 33%* on average in all participants. (Measured lasting results at 5–60 minutes and up to 4 hours after single 5–minute D’OXYVA delivery on skin surface, no reduction in PI levels.)